Gallagher Kathleen P. insider trades
Gallagher Kathleen P. has filed 13 Form 4s with the SEC that we hold, for RNAM (Chief Program Officer) and Atrium Therapeutics, Inc. (RNA) (See Remarks, Director). Across all of them we count 0 purchases worth $0 and 12 sales worth $1.2M reported on Form 4. None of these purchases or sales is dated in the last 12 months. The largest single trade was a sale of 5,875 shares of RNA worth $190.8K, dated 2025-06-02. The first filing on our record is dated 2025-01-08 and the latest 2026-09-22.
RNAM
| Trade date | Code | Shares | Value as filed | Filed |
|---|---|---|---|---|
| 2025-01-21 | S, sale reported on Form 4 | 1,295 | $37.0K | 2025-01-23 |
| 2025-01-21 | S, sale reported on Form 4 | 1,817 | $51.9K | 2025-01-23 |
| 2025-01-21 | S, sale reported on Form 4 | 670 | $19.2K | 2025-01-23 |
| 2025-01-22 | S, sale reported on Form 4 | 5,629 | $169.8K | 2025-01-23 |
| 2025-02-03 | S, sale reported on Form 4 | 5,875 | $188.9K | 2025-02-05 |
| 2025-03-03 | S, sale reported on Form 4 | 5,875 | $172.8K | 2025-03-04 |
| 2025-04-01 | S, sale reported on Form 4 | 5,546 | $154.3K | 2025-04-03 |
| 2025-04-01 | S, sale reported on Form 4 | 329 | $9.2K | 2025-04-03 |
| 2025-05-01 | S, sale reported on Form 4 | 5,875 | $190.3K | 2025-05-02 |
| 2025-06-02 | S, sale reported on Form 4 | 5,875 | $190.8K | 2025-06-04 |
| 2025-06-17 | S, sale reported on Form 4 | 911 | $27.5K | 2025-06-18 |
| 2025-09-02 | S, sale reported on Form 4 | 188 | $8.9K | 2025-09-02 |
Atrium Therapeutics, Inc. (RNA)
No purchase or sale of common stock reported here; these filings cover grants, option exercises or other codes.
Counted from the Form 4 filings this reporting owner (SEC CIK 2048409) filed on EDGAR. Values are the transaction values as filed. See every filing on EDGAR, or browse insider buying and today's insider purchases.
Source: U.S. Securities and Exchange Commission (EDGAR) and other official
government data · Updated 2026-10-12 ·
For informational purposes only, not investment advice.
Privacy · Terms